Combined determination of CYFRA 21-1 and CXCR1/2 levels for detecting recurrence in stage III squamous cell lung carcinoma
Despite efforts, tumor recurrence is diagnosed in 35–40% of patients with stage III squamous cell lung carcinoma (SCLC) during the...